Treatments with the Rag1 aphid resistance gene had the lowest CAD among treatments, regardless of location; however, these varieties were Group 1 and did not reach maturity in 2013. As a result, Rag1 varieties are not practical in ND until shorter-maturing varieties are developed with the Rag1 gene.